Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP691266.RAUvoyL51pTIFX-NB2uQ5jfLmAkInV46dnaz91BXg8Qks130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP691266.RAUvoyL51pTIFX-NB2uQ5jfLmAkInV46dnaz91BXg8Qks130_assertion type Assertion NP691266.RAUvoyL51pTIFX-NB2uQ5jfLmAkInV46dnaz91BXg8Qks130_head.
- NP691266.RAUvoyL51pTIFX-NB2uQ5jfLmAkInV46dnaz91BXg8Qks130_assertion description "[Compared to the control group, the Ad.BDNF treated group had lower psychophysical and electrophysiological thresholds as well as higher survival of spiral ganglion cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP691266.RAUvoyL51pTIFX-NB2uQ5jfLmAkInV46dnaz91BXg8Qks130_provenance.
- NP691266.RAUvoyL51pTIFX-NB2uQ5jfLmAkInV46dnaz91BXg8Qks130_assertion evidence source_evidence_literature NP691266.RAUvoyL51pTIFX-NB2uQ5jfLmAkInV46dnaz91BXg8Qks130_provenance.
- NP691266.RAUvoyL51pTIFX-NB2uQ5jfLmAkInV46dnaz91BXg8Qks130_assertion SIO_000772 18768155 NP691266.RAUvoyL51pTIFX-NB2uQ5jfLmAkInV46dnaz91BXg8Qks130_provenance.
- NP691266.RAUvoyL51pTIFX-NB2uQ5jfLmAkInV46dnaz91BXg8Qks130_assertion wasDerivedFrom befree-2016 NP691266.RAUvoyL51pTIFX-NB2uQ5jfLmAkInV46dnaz91BXg8Qks130_provenance.
- NP691266.RAUvoyL51pTIFX-NB2uQ5jfLmAkInV46dnaz91BXg8Qks130_assertion wasGeneratedBy ECO_0000203 NP691266.RAUvoyL51pTIFX-NB2uQ5jfLmAkInV46dnaz91BXg8Qks130_provenance.